Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$72.54 - $95.56 $12,404 - $16,340
171 Added 2.42%
7,246 $692,000
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $22,524 - $28,382
-365 Reduced 4.91%
7,075 $539,000
Q3 2023

Nov 20, 2023

BUY
$69.28 - $93.38 $9,422 - $12,699
136 Added 1.86%
7,440 $515,000
Q2 2023

Jul 27, 2023

SELL
$81.41 - $94.33 $14,165 - $16,413
-174 Reduced 2.33%
7,304 $688,000
Q1 2023

May 02, 2023

BUY
$74.26 - $84.51 $137,529 - $156,512
1,852 Added 32.92%
7,478 $618,000
Q4 2022

Feb 01, 2023

SELL
$68.3 - $87.44 $114,334 - $146,374
-1,674 Reduced 22.93%
5,626 $419,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $576 - $751
-7 Reduced 0.1%
7,300 $603,000
Q2 2022

Jul 25, 2022

SELL
$86.5 - $128.27 $303,615 - $450,227
-3,510 Reduced 32.45%
7,307 $695,000
Q1 2022

May 03, 2022

SELL
$101.96 - $128.34 $13,152 - $16,555
-129 Reduced 1.18%
10,817 $1.27 Million
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $2,021 - $2,482
19 Added 0.17%
10,946 $1.42 Million
Q3 2021

Oct 18, 2021

BUY
$102.91 - $122.75 $12,040 - $14,361
117 Added 1.08%
10,927 $1.24 Million
Q2 2021

Jul 12, 2021

BUY
$83.84 - $104.76 $77,635 - $97,007
926 Added 9.37%
10,810 $1.12 Million
Q1 2021

Apr 12, 2021

SELL
$78.68 - $90.67 $507,564 - $584,912
-6,451 Reduced 39.49%
9,884 $827,000
Q4 2020

Jan 11, 2021

BUY
$71.69 - $91.23 $5,161 - $6,568
72 Added 0.44%
16,335 $1.49 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $20,089 - $26,144
299 Added 1.87%
16,263 $1.37 Million
Q2 2020

Jul 14, 2020

BUY
$57.54 - $76.95 $632,940 - $846,450
11,000 Added 221.6%
15,964 $1.1 Million
Q1 2020

May 05, 2020

SELL
$52.41 - $81.0 $94,442 - $145,962
-1,802 Reduced 26.63%
4,964 $1.09 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $485,122 - $555,420
6,766 New
6,766 $1.58 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Hohimer Wealth Management, LLC Portfolio

Follow Hohimer Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hohimer Wealth Management, LLC with notifications on news.